查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1548169

全球栓塞治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Embolotherapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

全球栓塞治疗市场需求预计将从 2023 年的 48.7 亿美元达到近 106.8 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 9.12%。

栓塞疗法是一种透过引入栓塞剂来闭塞血管并治疗血管疾病的医疗技术。这种微创手术涉及将线圈、颗粒或液体製剂注射到血管中，以阻止或减少流向目标区域的血流。它可以治疗子宫肌瘤、某些类型的肿瘤和动静脉畸形等疾病。这种医疗技术旨在透过选择性阻断血液供应来缩小或消除异常生长、减少出血并缓解症状。该技术使用成像引导来确保栓塞材料的精确传递。它提供了比传统手术侵入性更小的选择，具有恢復时间更短和併发症风险更低等优点，使其成为当代介入放射学的宝贵财富。

市场动态

由于适合栓塞治疗的疾病（例如子宫肌瘤、动静脉畸形（AVM）和某些肿瘤）的盛行率不断增加，栓塞治疗市场正在扩大。这些疾病的发生率不断上升，以及人们越来越意识到栓塞疗法是一种有效的治疗选择，推动了市场的成长。技术进步为市场提供了巨大的机会。栓塞剂的创新，包括开发更有效和生物相容性材料，可增强治疗效果并扩大可透过栓塞疗法解决的病症范围。实时透视和 3D 成像等先进成像技术进一步提高了栓塞治疗程序的精确度和安全性，推动了其采用。

微创治疗的趋势也促进了市场的成长。栓塞疗法为传统手术方法提供了一种侵入性较小的替代方案，从而缩短了恢復时间并降低了併发症发生率。随着患者偏好转向微创选择，对栓塞治疗手术的需求预计将会上升。此外，扩大新兴市场的医疗服务范围也带来了成长机会。随着这些地区医疗保健基础设施的改善和介入放射学技术意识的提高，在先进治疗方法的普及和医疗保健投资的增加的推动下，栓塞疗法的采用可能会增长。然而，高成本和潜在的程序风险可能会抑制市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球栓塞治疗市场的每个细分市场进行了包容性评估。栓塞治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

栓塞疗法市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 栓塞剂
  • 微球
  • 栓塞弹簧圈（可拆式弹簧圈、可推弹簧圈）
  • 液态栓塞剂
  • 栓塞系统
  • 可拆卸气球
  • 支援设备
  • 微导管
  • 导丝

按疾病适应症

  • 癌症
  • 肝癌
  • 肾癌
  • 其他癌症
  • 周围血管疾病
  • 神经系统疾病
  • 脑动脉瘤
  • 脑动静脉畸形和瘻管
  • 胃肠道疾病
  • 泌尿系统和肾臟疾病

按程序分析

  • 经导管动脉栓塞术
  • 经导管动脉放射栓塞/选择性内放射治疗
  • 经动脉化疗栓塞术

透过最终用户分析

  • 医院和诊所
  • 门诊手术中心
  • 其他最终用户

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲栓塞治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。栓塞治疗市场的主要参与者包括 Merit Medical Systems、Boston Scientific Corporation、Medtronic Plc、Meril Life Sciences Pvt.。这部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：栓塞治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 依疾病适应症进行的市场吸引力分析
    • 透过程式分析进行市场吸引力分析
    • 最终用户分析的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球栓塞治疗市场分析：按产品

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 栓塞剂
  • 微球
  • 栓塞弹簧圈（可拆式弹簧圈、可推弹簧圈）
  • 液态栓塞剂
  • 栓塞系统
  • 可拆卸气球
  • 支援设备
  • 微导管
  • 导丝

第 6 章：全球栓塞治疗市场分析：依疾病适应症

  • 按疾病适应症概述
  • 按疾病迹象进行历史和预测数据分析
  • 癌症
  • 肝癌
  • 肾癌
  • 其他癌症
  • 周围血管疾病
  • 神经系统疾病
  • 脑动脉瘤
  • 脑动静脉畸形和瘻管
  • 胃肠道疾病
  • 泌尿系统和肾臟疾病

第 7 章：全球栓塞治疗市场分析：按程序分析

  • 按程序分析概述
  • 透过程式分析进行历史和预测资料分析
  • 经导管动脉栓塞术
  • 经导管动脉放射栓塞/选择性内放射治疗
  • 经动脉化疗栓塞术

第 8 章：全球栓塞治疗市场分析：按最终用户分析

  • 最终用户分析概述
  • 透过最终用户分析进行历史和预测数据分析
  • 医院和诊所
  • 门诊手术中心
  • 其他最终用户

第 9 章：全球栓塞治疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：栓塞治疗公司的竞争格局

  • 栓塞治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Merit Medical Systems
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Boston Scientific Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Medtronic Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Meril Life Sciences Pvt. Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112115503

The global demand for Embolotherapy Market is presumed to reach the market size of nearly USD 10.68 Billion by 2032 from USD 4.87 Billion in 2023 with a CAGR of 9.12% under the study period 2024-2032.

Embolotherapy is a medical technique used to occlude blood vessels and treat vascular conditions by introducing embolic agents. This minimally invasive procedure involves injecting coils, particles, or liquid agents into blood vessels to block or reduce blood flow to targeted areas. It manages conditions like uterine fibroids, certain types of tumors, and arteriovenous malformations. This medical technique aims to shrink or eliminate abnormal growths, reduce bleeding, and alleviate symptoms by selectively blocking the blood supply. This technique uses imaging guidance to ensure precise delivery of the embolic material. It provides a less invasive option than traditional surgery, offering advantages like shorter recovery time and a lower risk of complications, making it a valuable asset in contemporary interventional radiology.

MARKET DYNAMICS

The embolotherapy market is expanding due to the increasing prevalence of conditions amenable to embolotherapy, such as uterine fibroids, arteriovenous malformations (AVMs), and certain tumors. The rising incidence of these conditions and the growing awareness of embolotherapy as an effective treatment option fuel market growth. Technological advancements provide substantial opportunities for the market. Innovations in embolic agents, including developing more effective and biocompatible materials, enhance treatment outcomes and expand the range of conditions that can be addressed through embolotherapy. Advanced imaging technologies, such as real-time fluoroscopy and 3D imaging, further improve the precision and safety of embolotherapy procedures, driving adoption.

The trend towards minimally invasive treatments is also contributing to market growth. Embolotherapy offers a less invasive alternative to traditional surgical approaches, leading to reduced recovery times and lower complication rates. As patient preference shifts towards minimally invasive options, the demand for embolotherapy procedures is expected to rise. Additionally, expanding healthcare access in emerging markets presents growth opportunities. As healthcare infrastructure improves and awareness of interventional radiology techniques increases in these regions, adopting embolo therapy is likely to grow, driven by enhanced access to advanced treatments and increasing healthcare investment. However, high costs and potential procedural risks can restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Embolotherapy. The growth and trends of Embolotherapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Embolotherapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Embolic agents
  • Microspheres
  • Embolic coils (Detachable Coils, Pushable Coils)
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Detachable Balloons
  • Support Devices
  • Microcatheters
  • Guidewires

By Disease Indication

  • Cancer
  • Liver Cancer
  • Kidney Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Neurological Diseases
  • Cerebral Aneurysm
  • Cerebral Arteriovenous Malformations and Fistulas
  • Gastrointestinal Disorders
  • Urological and Nephrological Disorders

By Procedure Analysis

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

By End User Analysis

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Embolotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Embolotherapy market include Merit Medical Systems, Boston Scientific Corporation, Medtronic Plc, Meril Life Sciences Pvt. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EMBOLOTHERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Disease Indication
    • 3.7.3 Market Attractiveness Analysis By Procedure Analysis
    • 3.7.4 Market Attractiveness Analysis By End User Analysis
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Embolic agents Historic and Forecast Sales By Regions
  • 5.4. Microspheres Historic and Forecast Sales By Regions
  • 5.5. Embolic coils (Detachable Coils, Pushable Coils) Historic and Forecast Sales By Regions
  • 5.6. Liquid Embolic Agents Historic and Forecast Sales By Regions
  • 5.7. Embolic Plug Systems Historic and Forecast Sales By Regions
  • 5.8. Detachable Balloons Historic and Forecast Sales By Regions
  • 5.9. Support Devices Historic and Forecast Sales By Regions
  • 5.10. Microcatheters Historic and Forecast Sales By Regions
  • 5.11. Guidewires Historic and Forecast Sales By Regions

6. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY DISEASE INDICATION

  • 6.1. Overview By Disease Indication
  • 6.2. Historical and Forecast Data Analysis By Disease Indication
  • 6.3. Cancer Historic and Forecast Sales By Regions
  • 6.4. Liver Cancer Historic and Forecast Sales By Regions
  • 6.5. Kidney Cancer Historic and Forecast Sales By Regions
  • 6.6. Other Cancers Historic and Forecast Sales By Regions
  • 6.7. Peripheral Vascular Diseases Historic and Forecast Sales By Regions
  • 6.8. Neurological Diseases Historic and Forecast Sales By Regions
  • 6.9. Cerebral Aneurysm Historic and Forecast Sales By Regions
  • 6.10. Cerebral Arteriovenous Malformations and Fistulas Historic and Forecast Sales By Regions
  • 6.11. Gastrointestinal Disorders Historic and Forecast Sales By Regions
  • 6.12. Urological and Nephrological Disorders Historic and Forecast Sales By Regions

7. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY PROCEDURE ANALYSIS

  • 7.1. Overview By Procedure Analysis
  • 7.2. Historical and Forecast Data Analysis By Procedure Analysis
  • 7.3. Transcatheter Arterial Embolization Historic and Forecast Sales By Regions
  • 7.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Historic and Forecast Sales By Regions
  • 7.5. Transarterial Chemoembolization Historic and Forecast Sales By Regions

8. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY END USER ANALYSIS

  • 8.1. Overview By End User Analysis
  • 8.2. Historical and Forecast Data Analysis By End User Analysis
  • 8.3. Hospitals and Clinics Historic and Forecast Sales By Regions
  • 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 8.5. Other End Users Historic and Forecast Sales By Regions

9. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EMBOLOTHERAPY COMPANIES

  • 10.1. Embolotherapy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF EMBOLOTHERAPY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Merit Medical Systems
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Boston Scientific Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Medtronic Plc
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Meril Life Sciences Pvt. Ltd
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Embolic agents Market Sales By Geography (USD MN)
  • Microspheres Market Sales By Geography (USD MN)
  • Embolic coils (Detachable Coils, Pushable Coils) Market Sales By Geography (USD MN)
  • Liquid Embolic Agents Market Sales By Geography (USD MN)
  • Embolic Plug Systems Market Sales By Geography (USD MN)
  • Detachable Balloons Market Sales By Geography (USD MN)
  • Support Devices Market Sales By Geography (USD MN)
  • Microcatheters Market Sales By Geography (USD MN)
  • Guidewires Market Sales By Geography (USD MN)
  • Analysis By Disease Indication (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Kidney Cancer Market Sales By Geography (USD MN)
  • Other Cancers Market Sales By Geography (USD MN)
  • Peripheral Vascular Diseases Market Sales By Geography (USD MN)
  • Neurological Diseases Market Sales By Geography (USD MN)
  • Cerebral Aneurysm Market Sales By Geography (USD MN)
  • Cerebral Arteriovenous Malformations and Fistulas Market Sales By Geography (USD MN)
  • Gastrointestinal Disorders Market Sales By Geography (USD MN)
  • Urological and Nephrological Disorders Market Sales By Geography (USD MN)
  • Analysis By Procedure Analysis (USD MN)
  • Transcatheter Arterial Embolization Market Sales By Geography (USD MN)
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Market Sales By Geography (USD MN)
  • Transarterial Chemoembolization Market Sales By Geography (USD MN)
  • Analysis By End User Analysis (USD MN)
  • Hospitals and Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End Users Market Sales By Geography (USD MN)
  • Global Embolotherapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Embolotherapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Embolotherapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease Indication
  • Market Attractiveness Analysis By Procedure Analysis
  • Market Attractiveness Analysis By End User Analysis
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Embolic agents Market Sales By Geography (USD MN)
  • Microspheres Market Sales By Geography (USD MN)
  • Embolic coils (Detachable Coils, Pushable Coils) Market Sales By Geography (USD MN)
  • Liquid Embolic Agents Market Sales By Geography (USD MN)
  • Embolic Plug Systems Market Sales By Geography (USD MN)
  • Detachable Balloons Market Sales By Geography (USD MN)
  • Support Devices Market Sales By Geography (USD MN)
  • Microcatheters Market Sales By Geography (USD MN)
  • Guidewires Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Indication (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Kidney Cancer Market Sales By Geography (USD MN)
  • Other Cancers Market Sales By Geography (USD MN)
  • Peripheral Vascular Diseases Market Sales By Geography (USD MN)
  • Neurological Diseases Market Sales By Geography (USD MN)
  • Cerebral Aneurysm Market Sales By Geography (USD MN)
  • Cerebral Arteriovenous Malformations and Fistulas Market Sales By Geography (USD MN)
  • Gastrointestinal Disorders Market Sales By Geography (USD MN)
  • Urological and Nephrological Disorders Market Sales By Geography (USD MN)
  • Global Market Analysis By Procedure Analysis (USD MN)
  • Transcatheter Arterial Embolization Market Sales By Geography (USD MN)
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Market Sales By Geography (USD MN)
  • Transarterial Chemoembolization Market Sales By Geography (USD MN)
  • Global Market Analysis By End User Analysis (USD MN)
  • Hospitals and Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End Users Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.